Pharmacovigilance and Drug Safety Software Strategic Market Report 2024-2030: Rising Focus on Patient Safety and Adverse Event Reporting Bolster Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmacovigilance and Drug Safety Software - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Pharmacovigilance and Drug Safety Software was estimated at US$216.1 Million in 2023, and is projected to reach US$321.1 Million by 2030, growing at a CAGR of 5.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The Pharmacovigilance and Drug Safety Software Market is experiencing notable growth, with the ADR Reporting Functionality segment projected to reach US$146.0 Million by 2030, growing at a CAGR of 5.4%. The Drug Safety Audits Functionality segment is also set to expand at a robust CAGR of 6.1% over the analysis period. Regionally, the U.S. market is valued at $58.3 Million in 2023, while China is forecasted to grow at a 5.5% CAGR to reach $50.5 Million by 2030. Additional key regions, including Japan, Canada, Germany, and the Asia-Pacific, are also showing strong growth trends.

This report features comprehensive market data, providing an independent analysis of annual sales and forecasts in US$ Million from 2023 to 2030. It includes in-depth regional analysis, offering detailed insights into major markets such as North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. Company profiles highlight key players like AB Cube, ArisGlobal LLC, and Ennov USA, among others. Additionally, the report offers complimentary updates for one year, ensuring readers remain informed about the latest market developments.

By purchasing this report, readers will gain access to a thorough analysis of the global pharmacovigilance and drug safety software market, covering all major geographic regions and market segments. The report provides insights into the competitive landscape, including the regional presence of significant players, future trends, and the key drivers shaping the market. It also offers actionable insights, enabling readers to identify new revenue opportunities and make informed strategic decisions.

Key Questions Answered:

• How is the Global Pharmacovigilance and Drug Safety Software Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Key Attributes:

Report Attribute	Details
No. of Pages	181
Forecast Period	2023 - 2030
Estimated Market Value (USD) in 2023	$216.1 Million
Forecasted Market Value (USD) by 2030	$321.1 Million
Compound Annual Growth Rate	5.8%
Regions Covered	Global

Key Topics Covered:

MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Pharmacovigilance and Drug Safety Software - Global Key Competitors Percentage Market Share in 2024 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• Global Economic Update

MARKET TRENDS & DRIVERS

• Increasing Regulatory Requirements for Drug Safety and Monitoring
• Advances in AI and Machine Learning Enhance Pharmacovigilance Capabilities
• Growth in Pharmaceutical Industry Drives Demand for Drug Safety Solutions
• Rising Focus on Patient Safety and Adverse Event Reporting
• Expansion of Global Pharmacovigilance Network
• Increasing Complexity of Drug Development and Safety Monitoring
• Technological Advancements in Data Analytics and Big Data
• Demand for Cloud-Based Pharmacovigilance Solutions
• Rising Investment in Healthcare IT Infrastructure
• Development of Integrated Pharmacovigilance Systems
• Increasing Use of Real-World Data and Evidence
• Adoption of Automation and Robotics in Drug Safety Processes
• Expansion of Clinical Trials and Post-Marketing Surveillance

FOCUS ON SELECT PLAYERS (Total 47 Featured)

• AB Cube
• ArisGlobal LLC
• Ennov USA
• Extedo GmbH
• Online Business Applications, Inc.
• Oracle Corporation
• Sarjen Systems Pvt. Ltd.
• Sparta Systems, Inc.
• United Biosource Corporation

For more information about this report visit https://www.researchandmarkets.com/r/log5ul

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.